Prognostic factors assessed for 15,096 patients with colon cancer in stages I and II

World Journal of Surgery

Volumn 36, Issue 7, 2012, Pages 1693-1698

  Mroczkowski, Pawel ^a   Schmidt, Uwe ^b   Sahm, Maik ^c   Gastinger, Ingo ^a   Lippert, Hans ^a   Kube, Rainer ^a,d  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b StatConsult GmbH   (Germany)

^c Red Cross Clinic   (Germany)

^d CARL THIEM KLINIKUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; COLON TUMOR; COLORECTAL TUMOR; COMORBIDITY; DISEASE FREE SURVIVAL; FEMALE; GERMANY; HUMAN; MALE; METASTASIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE; TUMOR RECURRENCE;

AGE FACTORS; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; COMORBIDITY; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS;

EID: 84864284776     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1531-2     Document Type: Article

References (33)

1. Moertel CG, Fleming TR, MacDonald JS et al (1995) Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 122(5):321-326
2. Chok K, Law W (2007) Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg 31(7):1485-1490. doi:10.1007/s00268-007-9089-0 (Pubitemid 46945379)
3. Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American pathologists consensus statement 1999. Arch Pathol Lab Med 124(7):979-994
4. Hammond ME, Fitzgibbons PL, Compton CC et al (2000) College of American pathologists conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer committee and conference participants. Arch Pathol Lab Med 124(7):958-965 (Pubitemid 30602037)
5. Schmiegel W, Pox C, Reinacher-Schick A et al (2010) S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference, February 6-7, 2004 and June 8-9, 2007 (for the topics IV, VI and VII). Z Gastroenterol 48(1):65-136
6. Mroczkowski P, Kube R, Schmidt U et al (2011) Quality assessment of colorectal cancer care: an international online model. Colorectal Dis 13(8):890-895
7. UICC (2004) In: Wittekind C, Klimpfinger M, Sobin LH (eds) TNM-atlas: illustrierter leitfaden zur TNM/pTNM-klassifikation maligner tumoren, 5. Auflage, Springer, Berlin, pp 101-113
8. UICC (2002) In: Sobin LH, Wittekind C (eds) TNM classification of malignant tumors, 6th edn. Wiley, New York, pp 72-76
9. Merkel S, Mansmann U, Papadopoulos T et al (2001) The prognostic inhomogeneity of colorectal carcinomas stage III: a proposal for subdivision of stage III. Cancer 92(11):2754-2759 (Pubitemid 33091911)
10. Greene FL, Stewart AK, Norton HJ (2002) A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 236(4):416-421
11. O'Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American joint committee on cancer, 6th edition staging. JNCI J Natl Cancer Inst 96(19):1420-1425 (Pubitemid 39429665)
12. Burke HB (2004) Outcome prediction and the future of the TNM staging system. JNCI J Natl Cancer Inst 96(19):1408-1409 (Pubitemid 39429654)
13. Jeong SY, Chessin DB, Schrag D et al (2005) Re: colon cancer survival rates with the new American joint committee on cancer, 6th edition staging. JNCI J Natl Cancer Inst 97(22):1705-1706
14. O'Connor ES, Greenblatt DY, LoConte NK et al (2011) Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol 29(25):3381-3388
15. Rosenberg R, Friederichs J, Schuster T et al (2008) Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg 248(6):968-978
16. Storli KE, Sondenaa K, Bukholm IR et al (2011) Overall survival after resection for colon cancer in a national cohort study was adversely affected by TNM stage, lymph node ratio, gender, and old age. Int J Colorectal Dis 26(10):1299-1307
17. Saha AK, Smith KJ, Sue-Ling H et al (2011) Prognostic factors for survival after curative resection of Dukes' B colonic cancer. Colorectal Dis 13(12):1390-1394
18. Roxburgh CS, Wallace AM, Guthrie GK et al (2010) Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative surgery for colon cancer. Colorectal Dis 12(10):987-994
19. van Leeuwen BL, Pahlman L, Gunnarsson U et al (2008) The effect of age and gender on outcome after treatment for colon carcinoma. A population-based study in the Uppsala and Stockholm region. Crit Rev Oncol Hematol 67(3):229-236
20. Kornmann M, Formentini A, Ette C et al (2008) Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment. Eur J Surg Oncol 34(12): 1316-1321
21. Fietkau R, Zettl H, Klocking S et al (2004) Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock cancer registry. Strah-lenther Onkol 180(8):478-487
22. Huh JW, Kim HR, Kim YJ (2010) Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer. J Gastrointest Surg 14(7):1074-1080
23. Janssen-Heijnen ML, Houterman S, Lemmens VE et al (2005) Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 55(3):231-240 (Pubitemid 41222320)
24. Baxter NN, Virnig DJ, Rothenberger DA et al (2005) Lymph node evaluation in colorectal cancer patients: a population-based study. JNCI J Natl Cancer Inst 97(3):219-225 (Pubitemid 40277372)
25. Garcia-Saenz JA, Saenz MC, Gonzalez L, Perez-Segura P, Puente J, Lopez-Tarruella S, Sastre J, Casado A, Lopez-Asenjo JG, Az-Rubio E (2006) Significance of the immunohistochemical detection of lymph node micrometastases in stage II colorectal carcinoma. Clin Transl Oncol 8(9):676-680
26. Iddings D, Ahmad A, Elashoff D et al (2006) The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann Surg Oncol 13(11):1386-1392 (Pubitemid 44749649)
27. Catalano V, Loupakis F, Graziano F et al. (2011) Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Ann Oncol. (Epub ahead of print)
28. Zlobec I, Lugli A (2008) Prognostic and predictive factors in colorectal cancer. J Clin Pathol 61(5):561-569 (Pubitemid 351688621)
29. Sinicrope FA, Rego RL, Okumura K et al (2008) Prognostic impact of Bim, Puma, and Noxa expression in human colon carcinomas. Clin Cancer Res 14(18):5810-5818
30. Garman KS, Acharya CR, Edelman E et al (2008) A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities. Proc Natl Acad Sci USA 105(49):19432-19437
31. Anjomshoaa A, Lin YH, Black MA et al (2008) Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer. Br J Cancer 99(6): 966-973
32. German Breast Group Web site (2011) Register zur patientenselbstauskunft. http://www.germanbreastgroup.de/langzeitfup.html. Accessed 25 Jan 2011
33. Schippinger W, Samonigg H, Schaberl-Moser R et al (2007) A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer. Br J Cancer 97(8):1021-1027 (Pubitemid 47587021)